Free Trial
→ This is likely to EXPLODE (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$0.32
-10.4%		$2.50
$0.31
▼
$19.11
$27.55M1.843.69 million shs5.95 million shs
Nova Ltd. stock logo
NVMI
Nova
$327.64
-3.8%		$345.66
$266.43
▼
$615.99
$10.41B1.85436,500 shs274,028 shs
The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-11.75%-9.72%-89.26%-97.35%-96.94%
Nova Ltd. stock logo
NVMI
Nova
+4.58%+15.33%+0.06%-17.22%+10.27%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$0.32
-10.4%		$2.50
$0.31
▼
$19.11
$27.55M1.843.69 million shs5.95 million shs
Nova Ltd. stock logo
NVMI
Nova
$327.64
-3.8%		$345.66
$266.43
▼
$615.99
$10.41B1.85436,500 shs274,028 shs
The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-11.75%-9.72%-89.26%-97.35%-96.94%
Nova Ltd. stock logo
NVMI
Nova
+4.58%+15.33%+0.06%-17.22%+10.27%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
2.00
Hold$21.856,738.81% Upside
Nova Ltd. stock logo
NVMI
Nova
2.60
Moderate Buy$470.0043.45% Upside

Current Analyst Ratings Breakdown

Latest EYPT and NVMI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/9/2026
Nova Ltd. stock logo
NVMI
Nova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C) ➝ Hold (C+)
11/6/2026
Nova Ltd. stock logo
NVMI
Nova
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$600.00 ➝ $460.00
11/6/2026
Nova Ltd. stock logo
NVMI
Nova
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetOverweight$600.00 ➝ $500.00
11/5/2026
Nova Ltd. stock logo
NVMI
Nova
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetBuy$570.00 ➝ $420.00
10/20/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Laidlaw logo
Laidlaw
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeBuy ➝ Hold
10/20/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetSector Perform$1.00
10/20/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingNeutral
10/20/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeNeutral ➝ Underweight
10/20/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeOutperform ➝ Neutral$0.50
10/19/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeBuy ➝ Neutral
10/19/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeBuy ➝ Hold$1.00
(Data available from 11/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$2.79M9.88N/AN/A$3.70 per share0.09
Nova Ltd. stock logo
NVMI
Nova
$1.00B10.41$9.73 per share33.68$47.56 per share6.89
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$231.96M-$3.74N/AN/AN/A-10,994.73%-135.81%-108.35%11/12/2026 (Estimated)
Nova Ltd. stock logo
NVMI
Nova
$259.22M$8.8237.1524.921.4029.87%22.13%12.78%N/A

Latest EYPT and NVMI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.9304-$1.07-$0.1396-$1.07$0.23 million$0.76 million
11/5/2026Q3 2026
Nova Ltd. stock logo
NVMI
Nova
$2.77$2.86+$0.09$2.64$282.23 million$287.84 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Nova Ltd. stock logo
NVMI
Nova
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
4.50
4.46
Nova Ltd. stock logo
NVMI
Nova
0.49
6.21
5.39

Institutional Ownership

CompanyInstitutional Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Nova Ltd. stock logo
NVMI
Nova
82.99%

Insider Ownership

CompanyInsider Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
5.13%
Nova Ltd. stock logo
NVMI
Nova
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
21486.21 million81.79 millionOptionable
Nova Ltd. stock logo
NVMI
Nova
1,61231.78 million31.47 millionOptionable

Recent News About These Companies

Insider Selling: Nova (NASDAQ:NVMI) Director Sells $800,656.00 in Stock
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-nova-nasdaq-nvmi-director-sells-80065600-in-stock-2026-11-12/
Nova Ltd. (NASDAQ:NVMI) Stock Has Consensus Target Price of $470.00 According to Brokerages
November 12 at 3:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31193631
Stock Traders Buy High Volume of Nova Call Options (NASDAQ:NVMI)
November 11 at 1:21 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31190798
Nova Announces Participation in November and December Investor Conferences
November 10 at 8:31 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nova-announces-participation-in-november-and-december-investor-conferences?utm_source=marketbeat.com&utm_medium=referral
Nova to Participate in Investor Conferences in November and December
November 10 at 8:00 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/nova-to-participate-in-investor-conferences-in-november-and-december-302934798.html
Critical Survey: Nova (NASDAQ:NVMI) & Micron Technology (NASDAQ:MU)
November 10 at 5:00 AM  |  defenseworld.netD
Nova (NASDAQ:NVMI) Stock Sees Unusually High Call Option Buying
November 9 at 10:19 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/options-nova-nasdaq-nvmi-stock-sees-unusually-high-call-option-buying-2026-11-09/
Nova (NASDAQ:NVMI) Stock Gets Price Target Cut from Jefferies Financial Group
November 9 at 1:19 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31186805
Nova: Chip Complexity Is Driving Impressive Growth
November 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4964906-nova-chip-complexity-is-driving-impressive-growth
Nova (NASDAQ:NVMI) Shares Climb 10.9% After Strong Earnings
November 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31185224
Nova (NASDAQ:NVMI) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPS
November 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/earnings-nova-nasdaq-nvmi-posts-quarterly-earnings-results-beats-expectations-by-009-eps-2026-11-07/
Nova Ltd. (NASDAQ:NVMI) Stock Has Average Target Price of $470.00 According to Brokerages
November 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-nova-ltd-nasdaq-nvmi-stock-has-average-target-price-of-47000-according-to-brokerages-2026-11-07/
Wall Street Zen Upgrades Nova (NASDAQ:NVMI) to Hold
November 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31183290
Nova (NASDAQ:NVMI) Upgraded to Hold at Wall Street Zen
November 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-nova-nasdaq-nvmi-upgraded-to-hold-at-wall-street-zen-2026-11-07/
Is Nova (NVMI) Undervalued As Record Results Still Leave Its P E Looking Pricey?
November 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/nova-nvmi-undervalued-record-results-211400896.html
Nova (NASDAQ:NVMI) Stock Price Target Cut by Jefferies Financial Group
November 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-nova-nasdaq-nvmi-stock-price-target-cut-by-jefferies-financial-group-2026-11-06/
NVMI Q3 2026 deep dive: memory and packaging momentum propel record results
November 6, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/nvmi-q3-2026-deep-dive-memory-and-packaging-momentum-propel-record-results/ar-AA2gTrvO
Barclays Issues Pessimistic Forecast for Nova (NASDAQ:NVMI) Stock Price
November 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-barclays-issues-pessimistic-forecast-for-nova-nasdaq-nvmi-stock-price-2026-11-06/
Nova (NASDAQ:NVMI) Shares Climb 10.9% Following Better-Than-Expected Earnings
November 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-nova-nasdaq-nvmi-shares-climb-109-following-better-than-expected-earnings-2026-11-06/
Nova Q3 Earnings Call Highlights
November 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/transcript-nova-q3-earnings-call-highlights-2026-11-06/
Nova Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
November 6, 2026  |  marketscreener.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$0.32 -0.04 (-10.40%)
Closing price 04:00 PM Eastern
Extended Trading
$0.33 +0.01 (+4.23%)
As of 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Nova stock logo

Nova NASDAQ:NVMI

$327.64 -12.98 (-3.81%)
Closing price 04:00 PM Eastern
Extended Trading
$327.39 -0.25 (-0.08%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. The company serves various sectors of the integrated circuit manufacturing industry, including logic, foundries, and memory manufacturers, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd. in July 2021. Nova Ltd. was incorporated in 1993 and is headquartered in Rehovot, Israel.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas